A phase 1 trial involving controlled infection showed that CIS43LS was safe to use and effectively prevented infection with the malaria parasite.

中文翻译：

---

预防疟疾的抗体


一项涉及受控感染的 1 期试验表明，CIS43LS 使用安全，并能有效预防疟原虫感染。